Why the study?
Systemic non-physiological effects of cardiopulmonary bypass occur periprocedurally, but its long-term effects on ventricular function remain unclear.
Does off-pump CABG compared to on-pump CABG improve long-term left ventricular ejection fraction in patients with stable coronary artery disease and preserved ventricular function?
Does off-pump CABG compared to on-pump CABG improve long-term left ventricular ejection fraction in patients with stable coronary artery disease and preserved ventricular function?
Long-term left ventricular ejection fraction declines slightly but similarly after both on-pump and off-pump CABG in patients with stable CAD and initially preserved ventricular function.
Similar modest LVEF decline after ONCAB and OPCAB; confirms no long-term ventricular function advantage for off-pump CABG.
Background: Systemic non-physiological effects of cardiopulmonary bypass have been observed in the periprocedural period. Long-term assessment, including ventricular function (VF), is unclear. The objective of this study was to compare the evolution of left ventricular ejection fraction (LVEF) in a long-term follow-up among patients with coronary artery disease (CAD) who underwent off-pump (OPCAB) or on-pump coronary artery bypass graft (ONCAB).Methods: This study is a pre-specified analysis of the MASS III trial, a single-center and prospective study that enrolled patients with stable CAD initially preserved VF and randomized to OPCAB or ONCAB. They accomplished a new measure of LVEF by transthoracic echocardiogram in the follow-up, and the primary endpoint was the difference between final and baseline LVEF.Results: Of 308 patients randomized, 225 had a new evaluation of LVEF in a mean of 5.9 years of follow-up: 113 in ONCAB and 112 in the OPCAB group. Baseline characteristics were similar between groups, except for higher subjects with the 3-vessel disease in ONCAB. There was no difference in LVEF at the beginning (P=0.08) but, there was a discrete decrease in both LVEF for ONCAB and OPCAB groups (P <0.001 in both groups) in 5.9 years. Despite this, the decline was not significantly different between groups (delta of -6% for ONCAB and -5% for OPCAB; P=0.78). In a multivariate analysis, myocardial infarction was a predictor of LVEF <40%.Conclusions: Despite non-physiologic effects, there was no difference in the long-term follow-up of LVEF between the ONCAB and OPCAB groups in this studied sample.
No takes yet. Share an insight, caveat, or question.
Silva et al. (2022) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: